abstract |
Novel compounds of the formula (I), in which D, W, X, Y, T and R 1 are as defined in Patent Claim 1 , are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours. |